Biogen Inc. (BIIB)
FlaggedUS listed
This page tracks Biogen Inc. (BIIB) with live price data, technical indicators (RSI, MACD, moving averages, Sharpe ratio), and AI-powered analysis. Our scanner continuously reviews BIIB against ~5,000 North American equities — fusing market fundamentals with frontier AI to surface high-conviction opportunities before they break out.
New to these indicators? RSI, MACD, and moving averages explained — plus how AI forecasting works.
Latest AI Analysis
Updated Aug 10, 202641% confidenceThe pre-screen STRONG_SELL score of -1.15 reflects structural weakness: a 0.06 Sharpe ratio, 2.05% CAGR, -46% EPS growth, and 36.8 P/E all confirm deteriorating fundamentals and weak risk-adjusted returns. However, three specific contradictions prevent a confirmed SELL: (1) today's volume collapsed to 0.04x average, draining conviction from any directional move; (2) price sits above both rising SMA-50 and SMA-200, maintaining a near-term uptrend despite the downtrend-prone fundamentals; (3) recent Q2 earnings show growth portfolio revenue now exceeding legacy MS franchise for the second quarter, and the RayThera acquisition (completed Aug 6) signals M&A-driven pipeline bolstering. The Fear & Greed Index at 65 (Greed) also suggests near-term sentiment tailwinds. This is a deteriorating company in a brief technical rebound on light volume—a HOLD pending clarity on whether the acquisition and portfolio shift can arrest the EPS decline, or if volume expands to confirm either upside or downside.
BIIB AI Signal Track Record
Recent scanner signals for Biogen Inc.. Each is a point-in-time AI assessment, not a guarantee of future performance.
| Date | Signal | Confidence | Price at signal |
|---|---|---|---|
| Aug 10, 2026 | Flagged | 41% | $206.76 |
| Aug 10, 2026 | Flagged | 36% | $209.88 |
BIIB — Frequently Asked Questions
Is Biogen Inc. (BIIB) a buy right now?
As of August 10, 2026, StockTracker AI's screen flags BIIB as Flagged, with a ±2.4% typical 3-day move, based on its multi-factor technical screen and AI review. This is a technical screen and informational analysis, not financial advice or a recommendation to trade — confirm it against your own research and risk tolerance.
What is BIIB's RSI?
BIIB's 14-day RSI was 55.4 at the last scan — in neutral territory. RSI above 70 is generally considered overbought and below 30 oversold; the 40–60 band is neutral and is best read alongside trend and momentum rather than on its own.
What is the AI price forecast for BIIB?
StockTracker AI generates a probability-weighted 30-day price forecast for BIIB — a mathematical baseline (regression on recent prices) adjusted by an AI model for news, earnings proximity, and the current macro regime, with bull/base/bear scenarios. Sign in to generate the latest forecast.
How does StockTracker AI analyze BIIB?
Each scan screens BIIB on momentum, RSI, MACD, moving-average posture, Sharpe ratio, and 1-year CAGR to build a composite score, then a frontier AI model reviews the full picture — fundamentals, macro context, and recent news — to confirm or challenge the signal before it's surfaced.
Get the full picture for BIIB — free.
Add BIIB to a watchlist for instant scanner alerts. Run an on-demand 30-day AI price forecast. See the full historical signal track record. Free tier, no credit card.
Related stocks
Get scanner alerts and AI forecasts for BIIB
Free tier includes daily AI recommendations, charts with indicators, and a 3-stock watchlist. No credit card.
Get Started →